glp-1 market forecast Nutritional Support Size & Share 2025-2035 Market Overview: GLP-1 Agonists and

The goal is sustainable, long-term weight management rather than rapid weight loss

Molecular Nutrition & Food Research , 61 (3), 1600471

Though the mechanism(s) underlying the decreased risk of incident and recurrent CUD with semaglutide is unclear, several mechanisms could be involved

Inherited conditions like blue diaper syndrome and Hartnup disease can result in blue urine

This evaluation helps create a tailored treatment plan for weight loss and overall health

In 2023 the firm abandoned development of lotiglipron after trial participants showed elevated liver enzymes, and the same year discontinued a twice-daily danuglipron dosing regime after almost three quarters of treated patients experienced nausea, while almost a half developed vomiting and a quarter diarrhoea